versus the Host: Remodeling of the Bacterial Outer Membrane Is Required for Survival in the Gastric Mucosa

English version České info

Modification of bacterial surface structures, such as the lipid A portion of lipopolysaccharide (LPS), is used by many pathogenic bacteria to help evade the host innate immune response. Helicobacter pylori, a gram-negative bacterium capable of chronic colonization of the human stomach, modifies its lipid A by removal of phosphate groups from the 1- and 4′-positions of the lipid A backbone. In this study, we identify the enzyme responsible for dephosphorylation of the lipid A 4′-phosphate group in H. pylori, Jhp1487 (LpxF). To ascertain the role these modifications play in the pathogenesis of H. pylori, we created mutants in lpxE (1-phosphatase), lpxF (4′-phosphatase) and a double lpxE/F mutant. Analysis of lipid A isolated from lpxE and lpxF mutants revealed lipid A species with a 1 or 4′-phosphate group, respectively while the double lpxE/F mutant revealed a bis-phosphorylated lipid A. Mutants lacking lpxE, lpxF, or lpxE/F show a 16, 360 and 1020 fold increase in sensitivity to the cationic antimicrobial peptide polymyxin B, respectively. Moreover, a similar loss of resistance is seen against a variety of CAMPs found in the human body including LL37, β-defensin 2, and P-113. Using a fluorescent derivative of polymyxin we demonstrate that, unlike wild type bacteria, polymyxin readily associates with the lpxE/F mutant. Presumably, the increase in the negative charge of H. pylori LPS allows for binding of the peptide to the bacterial surface. Interestingly, the action of LpxE and LpxF was shown to decrease recognition of Helicobacter LPS by the innate immune receptor, Toll-like Receptor 4. Furthermore, lpxE/F mutants were unable to colonize the gastric mucosa of C57BL/6J and C57BL/6J tlr4 -/- mice when compared to wild type H. pylori. Our results demonstrate that dephosphorylation of the lipid A domain of H. pylori LPS by LpxE and LpxF is key to its ability to colonize a mammalian host.

Vyšlo v časopise: versus the Host: Remodeling of the Bacterial Outer Membrane Is Required for Survival in the Gastric Mucosa. PLoS Pathog 7(12): e32767. doi:10.1371/journal.ppat.1002454
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002454

Souhrn

Zdroje

1. ParsonnetJFriedmanGDVandersteenDPChangYVogelmanJH 1991 Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325 1127 1131

2. BlaserMJ 1996 The bacteria behind ulcers. Sci Am 274 104 107

3. AppelmelkBJShiberuBTrinksCTapsiNZhengPY 1998 Phase variation in Helicobacter pylori lipopolysaccharide. Infect Immun 66 70 76

4. WangGGeZRaskoDATaylorDE 2000 Lewis antigens in Helicobacter pylori: biosynthesis and phase variation. Mol Microbiol 36 1187 1196

5. RaetzCRWhitfieldC 2002 Lipopolysaccharide endotoxins. Annu Rev Biochem 71 635 700

6. RaetzCRReynoldsCMTrentMSBishopRE 2007 Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 76 295 329

7. GunnJSLimKBKruegerJKimKGuoL 1998 PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol Microbiol 27 1171 1182

8. DiamondGBeckloffNWeinbergAKisichKO 2009 The roles of antimicrobial peptides in innate host defense. Cur Pharma Design 15 2377 2392

9. PazgierMHooverDMYangDLuWLubkowskiJ 2006 Human beta-defensins. Cell Mol Life Sci 63 1294 1313

10. MatsonJSYooHJHakanssonKDiritaVJ 2010 Polymyxin B resistance in El Tor Vibrio cholerae requires lipid acylation catalyzed by MsbB. J Bacteriol 192 2044 2052

11. ClementsATullDJenneyAWFarnJLKimSH 2007 Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides. J Biol Chem 282 15569 15577

12. KimHMParkBSKimJIKimSELeeJ 2007 Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130 906 917

13. ErridgeC 2010 Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leuk Biol 87 989 999

14. WertsCTappingRIMathisonJCChuangTHKravchenkoV 2001 Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2 346 352

15. TobiasPS 1999 Lipopolysaccharide-Binding Protein. BradeHOpalSMVogelSNMorrisionDC Endotoxin in Health and Disease New York Marcel Dekker, Inc 359 367

16. TrentMSSteadCMTranAXHankinsJV 2006 Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res 12 205 223

17. TranAXWhittimoreJDWyrickPBMcGrathSCCotterRJ 2006 The lipid A 1-phosphatase of Helicobacter pylori is required for resistance to the antimicrobial peptide polymyxin. J Bacteriol 188 4531 4541

18. TranAXSteadCMTrentMS 2005 Remodeling of Helicobacter pylori lipopolysaccharide. J Endotoxin Res 11 161 166

19. SteadCMZhaoJRaetzCRTrentMS 2010 Removal of the outer Kdo from Helicobacter pylori lipopolysaccharide and its impact on the bacterial surface. Mol Microbiol 78 837 52

20. TranAXKarbarzMJWangXRaetzCRMcGrathSC 2004 Periplasmic cleavage and modification of the 1-phosphate group of Helicobacter pylori lipid A J Biol Chem 279 55780 55791

21. SteadCTranAFergusonDJrMcGrathSCotterR 2005 A novel 3-deoxy-D-manno-octulosonic acid (Kdo) hydrolase that removes the outer Kdo sugar of Helicobacter pylori lipopolysaccharide. J Bacteriol 187 3374 3383

22. SteadCMBeasleyACotterRJTrentMS 2008 Deciphering the unusual acylation pattern of Helicobacter pylori lipid A J Bacteriol 190 7012 7021

23. SchafferAAAravindLMaddenTLShavirinSSpougeJL 2001 Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res 29 2994 3005

24. PeekRM 2008 Helicobacter pylori infection and disease: from humans to animal models. Dis Models Mech 1 50 55

25. IsraelDASalamaNArnoldCNMossSFAndoT 2001 Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 107 611 620

26. ErmakTHGiannascaPJNicholsRMyersGANedrudJ 1998 Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 188 2277 2288

27. GutsmannTHaggeSODavidARoesSBohlingA 2005 Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides. J Endotoxin Res 11 167 173

28. BassoDPlebaniMKustersJG 2010 Pathogenesis of Helicobacter pylori infection. Helicobacter 15 Suppl 1 14 20

29. SalzmanNH 2008 Defensins versus bacteria: not just antibiotics anymore. Gastroenterol 134 2174 2177

30. PutsepKBrandenCIBomanHGNormarkS 1999 Antibacterial peptide from H. pylori. Nature 398 671 672

31. WangXRibeiroAAGuanZAbrahamSNRaetzCR 2007 Attenuated virulence of a Francisella mutant lacking the lipid A 4′-phosphatase. Proc Natl Acad Sci USA 104 4136 4141

32. CoatsSRJonesJWDoCTBrahamPHBainbridgeBW 2009 Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4′-phosphatase activities. Cell Microbiol 11 1587 1599

33. HajjarAMErnstRKTsaiJHWilsonCBMillerSI 2002 Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nature Immunol 3 354 359

34. ChenYYPengBYangQGlewMDVeithPD 2011 The outer membrane protein LptO is essential for the O-deacylation of LPS and the co-ordinated secretion and attachment of A-LPS and CTD proteins in Porphyromonas gingivalis. Mol Microbiol 79 1380 1401

35. Que-GewirthNLRibeiroAAKalbSRCotterRJBulachDM 2004 A methylated phosphate group and four amide-linked acyl chains in leptospira interrogans lipid A. The membrane anchor of an unusual lipopolysaccharide that activates TLR2. J Biol Chem 279 25420 25429

36. DarveauRPPhamTTLemleyKReifeRABainbridgeBW 2004 Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 72 5041 5051

37. SmithMFJrMitchellALiGDingSFitzmauriceAM 2003 Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 278 32552 32560

38. YokotaSOhnishiTMuroiMTanamotoKFujiiN 2007 Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex. FEMS Immunol Med Mic 51 140 148

39. HirschfeldMMaYWeisJHVogelSNWeisJJ 2000 Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165 618 622

40. ParkBSSongDHKimHMChoiBSLeeH 2009 The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458 1191 1195

41. QureshiNTakayamaKKurtzR 1991 Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect immun 59 441 444

42. SmithSMMoranAPDugganSPAhmedSEMohamedAS 2011 Tribbles 3: a novel regulator of TLR2-mediated signaling in response to Helicobacter pylori lipopolysaccharide. J Immunol 186 2462 2471

43. SanticMAl-KhodorSAbu KwaikY 2010 Cell biology and molecular ecology of Francisella tularensis. Cell Microbiol 12 129 139

44. CullenTWTrentMS 2010 A link between the assembly of flagella and lipooligosaccharide of the Gram-negative bacterium Campylobacter jejuni. Proc Natl Acad Sci U S A 107 5160 5165

45. IngramBOMasoudiARaetzCR 2010 Escherichia coli mutants that synthesize dephosphorylated lipid A molecules. Biochem 49 8325 8337

46. LoppnowHBradeHDurrbaumIDinarelloCAKusumotoS 1989 IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 142 3229 3238

47. QureshiNMascagniPRibiETakayamaK 1985 Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination. J Biol Chem 260 5271 5278

48. QureshiNTakayamaKRibiE 1982 Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J Biol Chem 257 11808 11815

49. KarbarzMJSixDARaetzCR 2009 Purification and characterization of the lipid A 1-phosphatase LpxE of Rhizobium leguminosarum. J Biol Chem 284 414 425

50. KundiM 2007 New hepatitis B vaccine formulated with an improved adjuvant system. Expert Rev Vaccines 6 133 140

51. BaldridgeJRMcGowanPEvansJTCluffCMossmanS 2004 Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther 4 1129 1138

52. JenksPJChevalierCEcobichonCLabigneA 2001 Identification of nonessential Helicobacter pylori genes using random mutagenesis and loop amplification. Res Microbiol 152 725 734

53. SkouloubrisSLabigneADe ReuseH 1997 Identification and characterization of an aliphatic amidase in Helicobacter pylori. Mol Microbiol 25 989 998

54. HaasRMeyerTFvan PuttenJP 1993 Aflagellated mutants of Helicobacter pylori generated by genetic transformation of naturally competent strains using transposon shuttle mutagenesis. Mol Microbiol 8 753 760

55. SmeetsLCBijlsmaJJBoomkensSYVandenbroucke-GraulsCMKustersJG 2000 comH, a novel gene essential for natural transformation of Helicobacter pylori. J Bacteriol 182 3948 3954

56. SmithPKKrohnRIHermansonGTMalliaAKGartnerFH 1985 Measurement of protein using bicinchoninic acid. Anal Biochem 150 76 85

57. WestphalOJannK 1965 Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. WhistlerRL Methods in carbohydrate chemistry New York Academic Press, Inc 83 91

58. HancockREW Hancock Laboratory Methods: Modified MIC Method for Cationic Antimicrobial Peptides Vancouvor, Canada Department of Microbiology and Immunology, University of British Columbia http://www.cmdr.ubc.ca/bobh/methods.htm. June 2009 ed

59. MoranAPLindnerBWalshEJ 1997 Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J Bacteriol 179 6453 6463